Thyroid diseases in primary Sjögren’s syndrome patients increase risks of malignancy and osteoporosis, driven by immune ...

Obesity and family practice experts share when it’s safe to prescribe GLP-1 receptor agonists to patients with thyroid ...

ICFO has now used the LUCA platform to characterize the thyroid tissue with simultaneous anatomical measurements, the first ...

Viridian Therapeutics stock popped Monday after the company scored a win in thyroid eye disease, a condition that causes the ...

This essential mineral is needed by your thyroid gland to produce hormones that regulate your body's metabolic rate. If you ...

A new study conducted at the Huazhong University of Science and Technology (Wuhan, China) found that liver fibrosis is highly ...

Viridian Therapeutics advances promising therapies for thyroid eye disease. See why VRDN stock stands to benefit from a ...

In an interview with Ophthalmology Times, Alon Kahana, MD, PhD, discusses interleukin-6 and its role in autoimmune diseases, particularly thyroid eye disease, noting that a promising alternative under ...

THRIVE-2 met all primary and secondary endpoints at the 15-week primary analysis timepoint after 5 infusions of veligrotug.

Veligrotug is an investigational monoclonal antibody that inhibits the activity of insulin-like growth factor-1 receptor.